This podcast episode discusses the work of the European Center for Disease Prevention and Control (ECDC) in the field of microbiology and molecular surveillance, with a focus on genomic epidemiology. Catherine interviews Teresa, a virologist and epidemiologist working at ECDC, discussing her background and interest in the field. They explore the concept of molecular surveillance, which involves monitoring and analysing the genetic composition of pathogens to understand their characteristics and changes over time.
Teresa elaborates on ECDC's projects related to molecular surveillance, including the EU laboratory capacity surveys (EU LAB CAP survey) and the whole genome sequencing infrastructure support under the DG-HERA Incubator and the EU for Health initiative. The conversation delves into the importance of genomic epidemiology, its applications in disease control and prevention, and its role in tracking variants during the COVID-19 pandemic.
The podcast also introduces a training program initiated by ECDC to build capacity in genomic epidemiology and bioinformatics for public health professionals (GenEpi-BioTrain). Teresa explains the interdisciplinary nature of genomic epidemiology, combining genomics and epidemiology, and its applications in identifying virulence markers, tracking transmission patterns, and informing public health interventions.
The host inquires about the impact of genomic surveillance on decision-making at the national level, with Teresa highlighting its role in tracking variants, monitoring influenza viruses, and supporting outbreak investigations. The podcast emphasizes how genomic surveillance influences the composition of vaccines and enhances public health measures.
In conclusion, Teresa discusses the importance of ECDC's role in coordinating genomic surveillance data collection across member states, facilitating cross-country outbreak investigations, and supporting smaller countries with limited resources. The podcast encourages professionals to participate in ECDC's training programs in genomic epidemiology.